Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Cancer Research
Journal
Overview
Identity
View All
Overview
publication venue for
Abstract CT018: TMPRSS2-ERG and RB1 as candidate predictive biomarkers for efficacy in TALAPRO-2: Phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
. 84:CT018-CT018.
2024
Abstract PR-012: Proteogenomic analysis of enriched tumor epithelium identifies prognostic signatures and an increased dependency of homologous recombination proficient cells on bmi1 in high grade serous ovarian cancer
. 84:PR-012-PR-012.
2024
publisher
American Association for Cancer Research (AACR)
Publisher
Identity
International Standard Serial Number (ISSN)
1538-7445